Format

Send to

Choose Destination
Actas Dermosifiliogr. 2015 Nov;106(9):716-24. doi: 10.1016/j.ad.2015.06.005. Epub 2015 Aug 12.

Update on Hidradenitis Suppurative (Part II): Treatment.

[Article in English, Spanish]

Author information

1
Servicio de Dermatología, Hospital de Manises, Valencia, España. Electronic address: antmarto@hotmail.com.
2
Servicio de Dermatología, Hospital Universitario del Sureste, Arganda del Rey, Madrid, España.
3
Unidad de Gestión Clínica de Dermatología, Hospital Universitario Puerta del Mar , Cádiz, España.
4
Hospital General de Alicante, Alicante, España.
5
Hospital Virgen del Rocío, Sevilla, España.
6
Complejo Hospitalario de Pontevedra, Pontevedra, España.
7
Hospital de Santa Creu i Sant Pau, Barcelona, España.

Abstract

Although hidradenitis suppurativa is a common and serious skin condition, its treatment is not well established. It is now accepted that the moderate and severe forms of the disease are associated with marked systemic inflammation. The goal of treatment in hidradenitis suppurative is therefore to achieve systemic control of inflammation. In some cases, surgery may also be necessary to reduce the severity of the manifestations of cutaneous inflammation. Recent advances in our understanding of hidradenitis suppurativa have been accompanied by the emergence of novel approaches to its treatment, including the use of certain biologic drugs. Several clinical trials have been undertaken to test the effects of biologics (mainly adalimumab) in this setting. In this review, we analyze the different treatments available for hidradenitis suppurativa.

KEYWORDS:

Acne inversa; Acné inversa; Adalimumab; Biologic therapy; Cirugía; Hidradenitis suppurativa; Hidradenitis supurativa; Surgery; Systemic treatment; Terapia biológica; Terapia sistémica

PMID:
26277040
DOI:
10.1016/j.ad.2015.06.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Ediciones Doyma, S.L.
Loading ...
Support Center